ArticleJournal of the National Cancer Institute2024

Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.

Takayuki Sumiyoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.